Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study Comparing Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to MTX (SELECT-MONOTHERAPY)

ClinicalTrials.gov ID: NCT02706951

Public ClinicalTrials.gov record NCT02706951. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 8:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis With Inadequate Response to MTX

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study objective of Period 1 of this study is to compare the safety and efficacy (signs and symptoms) of upadacitinib 30 mg once daily (QD) alone and upadacitinib 15 mg QD alone versus continuing MTX alone adults with moderately to severely active rheumatoid arthritis (RA) with an inadequate response to MTX. The study objective of Period 2 is to evaluate the long term safety, tolerability, and efficacy of upadacitinib 30 mg QD and 15 mg QD in adults with RA who had completed Period 1.

Study identification

NCT ID
NCT02706951
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
648 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 23, 2016 (Actual)
Primary completion
Oct 2, 2017 (Actual)
Completion
Aug 10, 2022 (Actual)
Last update posted
Jan 30, 2024

2016 – 2022

United States locations

U.S. sites
52
U.S. states
22
U.S. cities
46
Facility City State ZIP Site status
Rheum Assoc of North Alabama /ID# 146009 Huntsville Alabama 35801 —
Alabama Medical Group, PC /ID# 153941 Mobile Alabama 36608-1787 —
ArthroCare Arthritis Care & Re /ID# 143751 Gilbert Arizona 85234 —
Elite Clinical Studies, LLC /ID# 143760 Phoenix Arizona 85018 —
University of Arizona Cancer Center - North Campus /ID# 147175 Tucson Arizona 85719-1478 —
NEA Baptist Womens Clinic /ID# 148904 Jonesboro Arkansas 72401 —
C.V. Mehta MD, Med Corporation /ID# 143762 Hemet California 92543 —
Arthritis Assoc & Osteo Ctr /ID# 147176 Colorado Springs Colorado 80920 —
Ctr Rheum, Immuno, Arthritis /ID# 143766 Fort Lauderdale Florida 33309 —
South Florida Research Ph I-IV /ID# 151983 Miami Springs Florida 33166-7225 —
Advent Clinical Research /ID# 143767 Pinellas Park Florida 33781 —
Sarasota Arthritis Center /ID# 146011 Sarasota Florida 34239 —
W. Broward Rheum Assoc Inc. /ID# 146010 Tamarac Florida 33321 —
Clinical Research West FL /ID# 148726 Tampa Florida 33603 —
SW FL Clin Res Ctr, Tampa, FL /ID# 143763 Tampa Florida 33609 —
University of South Florida /ID# 146004 Tampa Florida 33612 —
BayCare Medical Group, Inc. /ID# 151985 Tampa Florida 33614-7101 —
BayCare Medical Group, Inc. /ID# 163595 Tampa Florida 33614-7101 —
Jefrey D. Lieberman, MD, P.C. /ID# 151816 Decatur Georgia 30033 —
Great Lakes Clinical Trials /ID# 150935 Chicago Illinois 60640 —
PRN Professional Research Network of Kansas, LLC /ID# 143761 Wichita Kansas 67205 —
Ochsner Clinic Foundation /ID# 153573 Baton Rouge Louisiana 70836-6455 —
The Arthritis & Diabetes Clinic, Inc. /ID# 160809 Monroe Louisiana 71203 —
Vanguard Medical Research, LLC /ID# 153124 Shreveport Louisiana 71011 —
Mansfield Health Center /ID# 161627 Mansfield Massachusetts 02048 —
Quality Clinical Research Inc. /ID# 156415 Omaha Nebraska 68114 —
Dartmouth-Hitchcock Medical Center /ID# 146008 Lebanon New Hampshire 03756 —
Albuquerque Clinical Trials, Inc /ID# 147618 Albuquerque New Mexico 87102 —
Arthritis and Osteo Assoc /ID# 147177 Las Cruces New Mexico 88011 —
Coastal Carolina Health Care /ID# 149275 New Bern North Carolina 28562 —
STAT Research, Inc. /ID# 143770 Vandalia Ohio 45377-9464 —
Health Research Oklahoma /ID# 159550 Oklahoma City Oklahoma 73103-2400 —
Healthcare Research Consultant /ID# 147632 Tulsa Oklahoma 74135 —
Innovative Clinical Research /ID# 143757 Greenville South Carolina 29601 —
Nashville Arthritis and Rheumatology /ID# 162641 Nashville Tennessee 37203 —
Tekton Research, Inc. /ID# 159554 Austin Texas 78745 —
Diagnostic Group Integrated He /ID# 148725 Beaumont Texas 77701 —
Trinity Universal Res Assoc /ID# 150138 Carrollton Texas 75007 —
Arth and Osteo Clin Brazo Valley /ID# 160810 College Station Texas 77845 —
Adriana Pop-Moody MD Clinic PA /ID# 147627 Corpus Christi Texas 78404 —
Accurate Clinical Management /ID# 143768 Houston Texas 77004 —
Accurate Clinical Research /ID# 143769 Houston Texas 77089 —
Pioneer Research Solutions, Inc. /ID# 143765 Houston Texas 77098-5294 —
P&I Clinical Research /ID# 151358 Lufkin Texas 75904-3132 —
SW Rheumatology Res. LLC /ID# 147620 Mesquite Texas 75150 —
Sun Research Institute /ID# 159553 San Antonio Texas 78215 —
Arthritis Clinic of Central TX /ID# 149266 San Marcos Texas 78666 —
Adv Rheumatology of Houston /ID# 162609 The Woodlands Texas 77382 —
DM Clinical Research /ID# 151359 Tomball Texas 77375 —
Arthritis & Osteoporosis Clinic /ID# 143752 Waco Texas 76710 —
Ctr for Arth and Rheum Disease /ID# 143759 Chesapeake Virginia 23320 —
Aurora Rheumatology and Immunotherapy Center /ID# 160811 Franklin Wisconsin 53132 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 101 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02706951, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 30, 2024 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02706951 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →